Increased potency and decreased elimination of lamifiban, a GPIIb-IIIa antagonist, in patients with severe renal dysfunction - Lehne, G; Nordal, KP; Midtvedt, K; Goggin, T; Brosstad, F (Thromb Haemost, 1998)